Constipation and Constipation-predominant Irritable Bowel Syndrome: A Comparative Study Using Rome III Criteria

被引:19
|
作者
Rajindrajith, Shaman [1 ]
Devanarayana, Niranga M. [2 ]
Benninga, Marc A. [3 ]
机构
[1] Univ Kelaniya, Fac Med, Dept Paediat, Ragama, Sri Lanka
[2] Univ Kelaniya, Fac Med, Dept Physiol, Ragama, Sri Lanka
[3] Emma Childrens Hosp, Acad Med Ctr, Dept Paediat Gastroenterol & Nutr, Amsterdam, Netherlands
关键词
child abuse; constipation; irritable bowel syndrome; prevalence; somatization; QUALITY-OF-LIFE; FUNCTIONAL GASTROINTESTINAL DISORDERS; CHRONIC IDIOPATHIC CONSTIPATION; PEDIATRIC-PATIENTS; CHILDREN; ASSOCIATION; SYMPTOMS; SYMPTOMATOLOGY; ADOLESCENTS; PREVALENCE;
D O I
10.1097/MPG.0000000000001332
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: The aim of the present study is to compare functional constipation (FC) and constipation-predominant irritable bowel syndrome (IBS-C) in adolescents. Methods: A school-based survey was conducted involving adolescents ages 13 to 18 years. A set of validated questionnaires including Rome III questionnaire for functional gastrointestinal disorders in children/adolescents, somatization inventory, quality of life inventory, and childhood traumatic events inventory were used for data collection. FC and IBS-C were defined using Rome III criteria. Results: A total of 1792 adolescents (975 boys [45.4%]) were included in the analysis. Prevalence of FC and IBS-C were 7.7% and 1.6%, respectively. Bowel habits such as stool frequency < 3 per week (10% vs 44.9%, P < 0.0001), hard stools (20% vs 40.5%, P < 0.05), painful defecation (33.3% vs 56.5%, P < 0.05), large diameter stools (23.3% vs 50.7%, P < 0.01), stool withholding behavior (20% vs 44.2%, P < 0.05), were more commonly associated with FC than did IBS-C. Occurrence of fecal incontinence (0% vs 8%, P = 0.21), urgency (56.7% vs 66.7%, P = 0.65), and straining (56.7% vs 36.9%, P = 0.47) was not significantly different between IBS-C and FC. Exposure to physical abuse, emotional abuse, and sexual abuse was equally prevalent among adolescents with FC and IBS-C. There was no difference between somatization scores, and health-related quality of life between the 2 groups. Conclusions: Although bowel habits related to stool withholding are more prevalent in FC, than in IBS-C, they are more likely to be a spectrum of a disorder rather than 2 separate entities.
引用
收藏
页码:679 / 684
页数:6
相关论文
共 50 条
  • [21] The management of constipation-related functional gastrointestinal disorder (constipation-predominant irritable bowel syndrome)
    Amal F. Radwan
    Nagwa R. Ahmed
    Eman A. Sultan
    [J]. The Egyptian Journal of Internal Medicine, 2015, 27 (4) : 127 - 132
  • [22] Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation
    Abrahamsson, Hasse
    Ostlund-Lindqvist, Ann-Margret
    Nilsson, Ralf
    Simren, Magnus
    Gillberg, Per-Goran
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2008, 43 (12) : 1483 - 1488
  • [23] Clinical and anorectal manometry profile of patients with functional constipation and constipation-predominant irritable bowel syndrome
    Omesh Goyal
    Monika Bansal
    Ajit Sood
    [J]. Indian Journal of Gastroenterology, 2019, 38 : 211 - 219
  • [24] Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide
    Yu, Siegfried W. B.
    Rao, Satish S. C.
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2014, 7 (05): : 193 - 205
  • [25] White Matter Microstructural Similarity and Diversity of Functional Constipation and Constipation-predominant Irritable Bowel Syndrome
    Nan, Jiaofen
    Zhang, Liangliang
    Chen, Qiqiang
    Zong, Nannan
    Zhang, Peiyong
    Ji, Xing
    Ma, Shaohui
    Zhang, Yuchen
    Huang, Wei
    Du, Zhongzhou
    Xia, Yongquan
    Zhang, Ming
    [J]. JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 24 (01) : 107 - 118
  • [26] Constipation-Predominant Irritable Bowel Syndrome Complicating Asymptomatic Nonrotation of the Midgut
    Plackett, Timothy P.
    Myers, Jonathan
    Gagliano, Ronald A., Jr.
    [J]. JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2010, 110 (08): : 437 - 440
  • [27] Potential effects of sodium hyaluronate on constipation-predominant irritable bowel syndrome
    Cui, Li
    Zou, Shuting
    Liu, Jing
    Lv, Huixia
    Li, Hui
    Zhang, Zhenhai
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 127
  • [28] Cisapride treatment of constipation-predominant irritable bowel syndrome is not superior to placebo
    Ziegenhagen, DJ
    Kruis, W
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (07) : 744 - 749
  • [29] Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review
    Mosinska, Paula
    Salaga, Maciej
    Fichna, Jakub
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (03) : 275 - 286
  • [30] Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome
    Biniszewska, Olga
    Jacenik, Damian
    Tarasiuk, Aleksandra
    Fichna, Jakub
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (08) : 1039 - 1049